Connect Biopharma Holdings Free Cash Flow (FCF) History (CNTB)

Connect Biopharma Holdings reported −$51.6M in free cash flow for fiscal 2025, a decrease of $27.3M from the previous fiscal year, with a free cash flow margin of −80687.50%.

View full Connect Biopharma Holdings company overview

Connect Biopharma Holdings free cash flow by year

Connect Biopharma Holdings annual free cash flow

Fiscal yearPeriod endedFree cash flowChangeGrowthFCF margin
20252025-12-31−$51.6M−$27.3M—−80687.50%
20242024-12-31−$24.4M$23.5M—−93.58%
20232023-12-31−$47.8M$58.1M——
20222022-12-31−$105.9M−$17.8M——
20212021-12-31−$88.2M———

Connect Biopharma Holdings free cash flow growth trends

Connect Biopharma Holdings's latest reported quarter, Q2 2026, generated −$15.9M in free cash flow, a decrease of $3.0M year over year.

About the metric

What free cash flow means

Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.

Calculation and source

How free cash flow is calculated

TickerStat calculates free cash flow as reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.

Review Connect Biopharma Holdings source filings ↗

Community posts

It’s quiet here.

No posts about CNTB yet. Start the conversation.

Write the first post